Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,752Revenue $M985Net Margin (%)36.1Altman Z-Score14.5
Enterprise Value $M5,752EPS $5.7Operating Margin %54.7Piotroski F-Score5
P/E(ttm)16.4Beneish M-Score-2.5Pre-tax Margin (%)54.8Higher ROA y-yN
Price/Book10.110-y EBITDA Growth Rate %--Quick Ratio3.1Cash flow > EarningsY
Price/Sales5.95-y EBITDA Growth Rate %94.5Current Ratio3.2Lower Leverage y-yY
Price/Free Cash Flow14.2y-y EBITDA Growth Rate %58.9ROA % (ttm)47.9Higher Current Ratio y-yY
Dividend Yield %1.3PEG0.2ROE % (ttm)85.2Less Shares Outstanding y-yN
Payout Ratio %25.0Shares Outstanding M61.0ROIC % (ttm)199Gross Margin Increase y-yN

Gurus Latest Trades with QCOR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
QCORJohn Paulson 2014-09-30 Sold Out -0.9%$89.41 - $96.93
($93.2)
$ 93.600%Sold Out0
QCORJoel Greenblatt 2014-09-30 Sold Out -0.37%$89.41 - $96.93
($93.2)
$ 93.600%Sold Out0
QCORPrem Watsa 2014-09-30 Sold Out -0.04%$89.41 - $96.93
($93.2)
$ 93.600%Sold Out0
QCORMario Gabelli 2014-09-30 Sold Out $89.41 - $96.93
($93.2)
$ 93.600%Sold Out0
QCORJohn Paulson 2014-06-30 Buy 0.9%$67.87 - $93.18
($85.53)
$ 93.609%New holding2,248,913
QCORPrem Watsa 2014-06-30 Buy 0.04%$67.87 - $93.18
($85.53)
$ 93.609%New holding6,500
QCORMario Gabelli 2014-06-30 Buy $67.87 - $93.18
($85.53)
$ 93.609%New holding7,100
QCORDavid Dreman 2014-06-30 Sold Out $67.87 - $93.18
($85.53)
$ 93.609%Sold Out0
QCORJohn Paulson 2014-03-31 Sold Out -0.2%$50.19 - $79.46
($63.52)
$ 93.6047%Sold Out0
QCORDavid Dreman 2014-03-31 Buy $50.19 - $79.46
($63.52)
$ 93.6047%New holding806
QCORJohn Paulson 2013-12-31 Buy 0.2%$51.69 - $69.73
($59.18)
$ 93.6058%New holding731,410
QCORJoel Greenblatt 2013-12-31 Add0.14%$51.69 - $69.73
($59.18)
$ 93.6058%Add 55.43%296,803
QCORHOTCHKIS & WILEY 2013-09-30 Sold Out -0.11%$45.84 - $72.34
($59.68)
$ 93.6057%Sold Out0
QCORHOTCHKIS & WILEY 2013-06-30 Buy 0.11%$27.31 - $47.46
($35.47)
$ 93.60164%New holding475,700
QCORJoel Greenblatt 2012-12-31 Add0.11%$19.36 - $30.06
($25.56)
$ 93.60266%Add 57.57%185,698
QCORRon Baron 2012-09-30 Sold Out -0.33%$17.83 - $57.64
($41.37)
$ 93.60126%Sold Out0
QCORJoel Greenblatt 2012-09-30 Buy 0.15%$17.83 - $57.64
($41.37)
$ 93.60126%New holding117,854
QCORRon Baron 2012-03-31 Add0.12%$33.53 - $42.14
($34.79)
$ 93.60169%Add 107.64%1,010,400
QCORKen Heebner 2012-03-31 Sold Out -0.05%$33.53 - $42.14
($34.79)
$ 93.60169%Sold Out0
QCORRon Baron 2011-12-31 Buy 0.13%$26.36 - $45.59
($39.36)
$ 93.60138%New holding486,600
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

QCOR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


QCOR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BAILEY DON MSee Remarks 2014-08-13Sell40,000$91.961.78 view
Mulroy Michael H.See Remarks 2014-08-11Sell10,000$92.331.38 view
BAILEY DON MSee Remarks 2014-07-14Sell40,000$95.54-2.03 view
Mulroy Michael H.See Remarks 2014-07-10Sell10,000$90.892.98 view
Young DavidChief Scientific Officer 2014-06-24Sell6,000$91.961.78 view
BAILEY DON MPresident and CEO 2014-06-13Sell40,000$89.834.2 view
Mulroy Michael H.See Remarks 2014-06-10Sell10,000$88.575.68 view
FARRELL STEPHEN CDirector 2014-06-02Sell3,750$89.944.07 view
Medeiros David JeffreyEVP and CTO 2014-05-19Sell2,292$89.664.39 view
BAILEY DON MPresident and CEO 2014-05-13Sell40,000$87.057.52 view

Quarterly/Annual Reports about QCOR:

News about QCOR:

Articles On GuruFocus.com
Only Buy Luxury At A Deep Discount Apr 01 2015 
John Hussman Purchases 36 New Stocks in Q3 2014 Nov 13 2014 
Prem Watsa Buys 4 New Stocks Aug 13 2014 
Paulson Bets Again On Mallinckrodt Aug 07 2014 
Here are 5 Good Companies to Consider Investing In Right Now Feb 11 2014 
8 Stocks Trying to Be 'Good' by Raising Their Dividends Oct 14 2013 
4 Top-Performing Healthcare Dividend Stocks with Single-Digit P/Es Jul 02 2013 
My 3 Favorite Healthcare Dividend Stocks with Highest Float Short Ratio Jun 03 2013 
My 4 Favorites From The 20 Cheapest Healthcare Dividend Stock List May 02 2013 
comment on QCOR Apr 11 2013 

More From Other Websites
Mallinckrodt’s Questcor Said Facing Multistate Antitrust Probe Jun 17 2015
Mallinckrodt Tops Q2 Earnings & Revenues on Acquisitions - Analyst Blog May 05 2015
Mallinckrodt shares rise on earnings outlook Oct 14 2014
Mallinckrodt shares rise on earnings outlook Oct 14 2014
The Zacks Analyst Blog Highlights: magicJack VocalTec, RRSat Global Communications Network,... Aug 19 2014
Gulfmark Offshore (GFL) Now Added to S&P SmallCap 600 Index Aug 18 2014
Mallinckrodt Set to Join the S&P 500; Rowan to Join S&P MidCap 400; GulfMark Offshore to Join S&P... Aug 14 2014
QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Aug 14 2014
Mallinckrodt Completes Acquisition Of Questcor Pharmaceuticals Aug 14 2014
Mallinckrodt And Questcor Shareholders Approve Mallinckrodt's Acquisition Of Questcor Aug 14 2014
Prem Watsa Buys 4 New Stocks Aug 13 2014
Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide Aug 07 2014
Prescription Drugmakers Slide Down Industry Rankings Aug 04 2014
Institutional Shareholder Services Inc. And Glass Lewis Recommend That Shareholders Of Mallinckrodt... Aug 04 2014
QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Other Events Jul 30 2014
QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 25 2014
MS drug sales drive Questcor profit Jul 24 2014
Update-Moody's assigns Ba2 to Mallinckrodt's new sr. secured term loan Jul 15 2014
QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 10 2014
Mallinckrodt to buy Questcor Pharma for $5.6 bn Apr 07 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Cgrain@google
ReplyCgrain@google - 1 year ago
QCOR has legal issues that need to be resolved.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK